Brought to you by 
ObsEva gets rights to Merck Serono's preterm labor candidates
19 Jan 2017
Executive Summary
Merck KGAA’s Merck Serono SA division has granted women’s health start-up ObsEva SA worldwide rights to develop and sell certain preterm labor drug candidates.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com